Shankar Munusamy
| Title | Professor Clinical |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOP-DOCP General Operations |
|---|
|
|
|
Bibliographic
-
Munusamy S, Aeilts M, Koenigsfeld C, Torry RJ. Student Perceptions and the Impact of Mnemonics on Knowledge Retention and Application in Pharmacology Education. Am J Pharm Educ. 2025 Sep; 89(9):101480. PMID: 40749989.
-
Augustine JM, Munusamy S, Attarabeen OF. Erratum to "Best Practices for Teaching and Assessing Population Health and Wellness" [Am J Pharm Educ 89 (2025) 101359]. Am J Pharm Educ. 2025 Jun; 89(6):101421. PMID: 40413815.
-
Munusamy S, Hester M, Nelson MH, Torry RJ. Impact of Mindfulness Sessions and Weekly Wellness Messages on Pharmacy Students' Perceived Stress and Resilience. Am J Pharm Educ. 2025 Apr; 89(4):101385. PMID: 40032145.
-
Augustine JM, Munusamy S, Attarabeen OF. Best Practices for Teaching and Assessing Population Health and Wellness. Am J Pharm Educ. 2025 Feb; 89(2):101359. PMID: 39826895.
-
Van Dyke A, Cline KM, Morley S, Munusamy S, Mnatzaganian CL, Thurston MM. Prioritizing Faculty Well-Being: Why it Matters, What Schools Can Do, and a Call for Action. Am J Pharm Educ. 2024 Nov; 88(11):101286. PMID: 39251072.
-
Vordenberg SE, Fusco NM, Ward KE, Darley A, Brady JH, Culhane NS, Habib MJ, Hernandez E, Moye PM, Munusamy S, Painter JT, Pope N, Stevenson TL, Vanderboll K, Chase PA, Matsumoto RR. An Integrative Review of Micro-Credentials and Digital Badges for Pharmacy Educators. Am J Pharm Educ. 2024 Mar; 88(3):100660. PMID: 38272238.
-
Bayne S, LeFevre J, Olstinske K, Ravindran S, Munusamy S. Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease. Adv Biol (Weinh). 2024 03; 8(3):e2300496. PMID: 38065929.
-
Ramasamy T, Ruttala HB, Munusamy S, Chakraborty N, Kim JO. Corrigendum to "Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics" [Journal of Controlled Release 352 (2022) 861-878]. J Control Release. 2023 Feb; 354:34. PMID: 36586296.
-
Ramasamy T, Ruttala HB, Munusamy S, Chakraborty N, Kim JO. Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics. J Control Release. 2022 12; 352:861-878. PMID: 36397636.
-
Ravindran S, Munusamy S. Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. J Cell Physiol. 2022 02; 237(2):1182-1205. PMID: 34713897.
-
Ramasamy T, Munusamy S, Ruttala HB, Kim JO. Smart Nanocarriers for the Delivery of Nucleic Acid-Based Therapeutics: A Comprehensive Review. Biotechnol J. 2021 Feb; 16(2):e1900408. PMID: 32702191.
-
Rathinam A, Pari L, Venkatesan M, Munusamy S. Myrtenal attenuates oxidative stress and inflammation in a rat model of streptozotocin-induced diabetes. Arch Physiol Biochem. 2022 Feb; 128(1):175-183. PMID: 31564173.
-
El Gamal H, Eid AH, Munusamy S. Corrigendum to "Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury". Biomed Res Int. 2019; 2019:9406241. PMID: 31534968.
-
Ravindran S, Pasha M, Agouni A, Munusamy S. Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury. Biomolecules. 2019 08 06; 9(8). PMID: 31390845.
-
Pasha M, Sivaraman SK, Frantz R, Agouni A, Munusamy S. Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines. Biomolecules. 2019 03 22; 9(3). PMID: 30909494.
-
Benameur T, Osman A, Parray A, Ait Hssain A, Munusamy S, Agouni A. Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes. Oxid Med Cell Longev. 2019; 2019:6475187. PMID: 30915196.
-
Maamoun H, Benameur T, Pintus G, Munusamy S, Agouni A. Crosstalk Between Oxidative Stress and Endoplasmic Reticulum (ER) Stress in Endothelial Dysfunction and Aberrant Angiogenesis Associated With Diabetes: A Focus on the Protective Roles of Heme Oxygenase (HO)-1. Front Physiol. 2019; 10:70. PMID: 30804804.
-
Munusamy S, Osman A, Riaz S, Ali S, Mraiche F. The use of Socrative and Yammer online tools to promote interactive learning in pharmacy education. Curr Pharm Teach Learn. 2019 01; 11(1):76-80. PMID: 30527879.
-
Allouch S, Munusamy S. AMP-activated Protein Kinase as a Drug Target in Chronic Kidney Disease. Curr Drug Targets. 2018; 19(6):709-720. PMID: 28571536.
-
Sankaralingam S, Ibrahim A, Rahman MDM, Eid AH, Munusamy S. Role of Methylglyoxal in Diabetic Cardiovascular and Kidney Diseases: Insights from Basic Science for Application into Clinical Practice. Curr Pharm Des. 2018; 24(26):3072-3083. PMID: 30179128.
-
Pasha M, Eid AH, Eid AA, Gorin Y, Munusamy S. Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases. Oxid Med Cell Longev. 2017; 2017:3296294. PMID: 28690762.
-
Allouch S, Munusamy S. Metformin attenuates albumin-induced alterations in renal tubular cells in vitro. J Cell Physiol. 2017 Dec; 232(12):3652-3663. PMID: 28158902.
-
Hammad AS, Ravindran S, Khalil A, Munusamy S. Structure-activity relationship of piperine and its synthetic amide analogs for therapeutic potential to prevent experimentally induced ER stress in vitro. Cell Stress Chaperones. 2017 05; 22(3):417-428. PMID: 28397086.
-
El Gamal H, Eid AH, Munusamy S. Renoprotective Effects of Aldose Reductase Inhibitor Epalrestat against High Glucose-Induced Cellular Injury. Biomed Res Int. 2017; 2017:5903105. PMID: 28386557.
-
ElGamal H, Munusamy S. Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges. Protein Pept Lett. 2017; 24(1):71-77. PMID: 27894247.
-
Ravindran S, Kuruvilla V, Wilbur K, Munusamy S. Nephroprotective Effects of Metformin in Diabetic Nephropathy. J Cell Physiol. 2017 Apr; 232(4):731-742. PMID: 27627216.
-
Munusamy S, do Carmo JM, Hosler JP, Hall JE. Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin. Am J Physiol Renal Physiol. 2015 Oct 15; 309(8):F731-43. PMID: 26290368.
-
Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010 Jun 04; 285(23):17271-6. PMID: 20348094.
-
Munusamy S, MacMillan-Crow LA. Mitochondrial superoxide plays a crucial role in the development of mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells. Free Radic Biol Med. 2009 Apr 15; 46(8):1149-57. PMID: 19439219.
-
Munusamy S, Saba H, Mitchell T, Megyesi JK, Brock RW, Macmillan-Crow LA. Alteration of renal respiratory Complex-III during experimental type-1 diabetes. BMC Endocr Disord. 2009 Jan 23; 9:2. PMID: 19166612.
-
Saba H, Munusamy S, Macmillan-Crow LA. Cold preservation mediated renal injury: involvement of mitochondrial oxidative stress. Ren Fail. 2008; 30(2):125-33. PMID: 18300110.
-
Saba H, Batinic-Haberle I, Munusamy S, Mitchell T, Lichti C, Megyesi J, MacMillan-Crow LA. Manganese porphyrin reduces renal injury and mitochondrial damage during ischemia/reperfusion. Free Radic Biol Med. 2007 May 15; 42(10):1571-8. PMID: 17448904.
-
Sharma SS, Munusamy S, Thiyagarajan M, Kaul CL. Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J Neurosurg. 2004 Oct; 101(4):669-75. PMID: 15481724.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2004 | 1 | | 2007 | 1 | | 2008 | 1 | | 2009 | 2 | | 2010 | 1 | | 2015 | 1 | | 2016 | 1 | | 2017 | 5 | | 2018 | 3 | | 2019 | 6 | | 2020 | 1 | | 2021 | 1 | | 2022 | 2 | | 2023 | 1 | | 2024 | 2 | | 2025 | 4 |
To return to the timeline, click here.
|
Munusamy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|